Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $478.93 ($4.0M) on 2026-09-03, disclosed to the SEC on 2026-09-03.
Scheduled sale ($4.0M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $478.93 | 1,545 | $740K | 18.5% |
| 2 | $479.66 | 936 | $449K | 11.2% |
| 3 | $480.86 | 2,360 | $1.1M | 28.4% |
| 4 | $481.92 | 1,048 | $505K | 12.6% |
| 5 | $482.66 | 160 | $77K | 1.9% |
| 6 | $483.85 | 200 |
| $97K |
| 2.4% |
| 7 | $485.12 | 954 | $463K | 11.6% |
| 8 | $486.47 | 598 | $291K | 7.3% |
| 9 | $487.36 | 169 | $82K | 2.1% |
| 10 | $488.32 | 10 | $5K | 0.1% |
| 11 | $490.88 | 320 | $157K | 3.9% |
| Total | $482.03 avg | 8,300 | $4.0M | 100% |
| Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-07-16 | $4.4M | — | Filing → |